Susquehanna International Group, LLP 9 Meters Biopharma, Inc. Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.21 - $0.32 $31,094 - $47,381	-148,067 Reduced 83.82%	28,592 $6,000
Q2 2022 Aug 15, 2022	BUY	$0.26 - $0.64 $13,131 - $32,323	50,505 Added 40.03%	176,659 $46,000
Q1 2022 May 16, 2022	SELL	$0.52 - $1.0 $81,325 - $156,396	-156,396 Reduced 55.35%	126,154 $76,000
Q4 2021 Feb 14, 2022	BUY	$0.85 - $1.33 $206,298 - $322,796	242,704 Added 609.11%	282,550 $276,000
Q3 2021 Nov 15, 2021	SELL	$1.03 - $1.41 $436,208 - $597,139	-423,503 Reduced 91.4%	39,846 $52,000

Q2 2021 Aug 11, 2021	SELL	$1.04 - $1.5 $70,765 - $102,066	-68,044 Reduced 12.8%	463,349 $510,000
Q1 2021 May 17, 2021	BUY	$0.84 - $2.16 $446,370 - $1.15 Million	531,393 New	531,393 $622,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.